Literature DB >> 19506219

Risk alleles for multiple sclerosis in multiplex families.

M J D'Netto1, H Ward, K M Morrison, S V Ramagopalan, D A Dyment, G C DeLuca, L Handunnetthi, A D Sadovnick, G C Ebers.   

Abstract

OBJECTIVE: We assessed the hypotheses that non-major histocompatibility complex multiple sclerosis (MS) susceptibility loci would be common to sporadic cases and multiplex families, that they would have larger effects in multiplex families, and that the aggregation of susceptibility loci contributes to the increased prevalence of MS in such families.
METHODS: A set of 43 multiplex families comprising 732 individuals and 211 affected subjects was genotyped for 13 MS candidate genes identified by genome-wide association. A control data set of 182 healthy individuals was also genotyped to perform a case-control analysis alongside the family-based pedigree disequilibrium association test, although this may have been underpowered.
RESULTS: An effect of the IL2RA and CD58 loci was shown in multiplex families as in sporadic MS. The aggregate of the IL2RA, IL7R, EVI5, KIAA0350, and CD58 risk genotypes in affected individuals from multiplex families was found to be notably different from controls (chi(2) = 112, p = 1 x 10(-22)).
CONCLUSIONS: Although differences between individual families can only be suggested, the aggregate results in multiplex families demonstrate effect sizes that are increased as compared with those reported in previous studies for sporadic cases. In addition, they imply that concentrations of susceptibility alleles at IL2RA, IL7R, EVI5, KIAA0350, and CD58 are partly responsible for the heightened prevalence of multiple sclerosis within multiplex families.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506219     DOI: 10.1212/WNL.0b013e3181a92c25

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Multiple sclerosis genetics--is the glass half full, or half empty?

Authors:  Jorge R Oksenberg; Sergio E Baranzini
Journal:  Nat Rev Neurol       Date:  2010-07-13       Impact factor: 42.937

2.  IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.

Authors:  C C Walline; S Kanakasabai; J J Bright
Journal:  Genes Immun       Date:  2010-09-23       Impact factor: 2.676

3.  Unique ability of pandemic influenza to downregulate the genes involved in neuronal disorders.

Authors:  Esmaeil Ebrahimie; Zahra Nurollah; Mansour Ebrahimi; Farhid Hemmatzadeh; Jagoda Ignjatovic
Journal:  Mol Biol Rep       Date:  2015-08-06       Impact factor: 2.316

4.  Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.

Authors:  Pierre-Antoine Gourraud; Joseph P McElroy; Stacy J Caillier; Britt A Johnson; Adam Santaniello; Stephen L Hauser; Jorge R Oksenberg
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

Review 5.  The immunogenetic architecture of autoimmune disease.

Authors:  An Goris; Adrian Liston
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

Review 6.  Biomarkers in Multiple Sclerosis.

Authors:  Anu Paul; Manuel Comabella; Roopali Gandhi
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

7.  Genome-wide association filtering using a highly locus-specific transmission/disequilibrium test.

Authors:  María M Abad-Grau; Nuria Medina-Medina; Rosana Montes-Soldado; José Moreno-Ortega; Fuencisla Matesanz
Journal:  Hum Genet       Date:  2010-07-06       Impact factor: 4.132

Review 8.  Revealing the genetic basis of multiple sclerosis: are we there yet?

Authors:  Sergio E Baranzini
Journal:  Curr Opin Genet Dev       Date:  2011-01-17       Impact factor: 5.578

9.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

10.  Multiple sclerosis pharmacogenetics: personalized approach towards tailored therapeutics.

Authors:  Iris Grossman; Ariel Miller
Journal:  EPMA J       Date:  2010-06-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.